InvestorsHub Logo
Followers 154
Posts 2653
Boards Moderated 0
Alias Born 01/29/2004

Re: XenaLives post# 120632

Monday, 09/18/2017 11:48:49 AM

Monday, September 18, 2017 11:48:49 AM

Post# of 464083
Anavex 2-73 the 21st-Century Aspirin?

Not an inconceivable proposition.

First, it's profoundly safe --- as much as aspirin (which can cause internal bleeding).

And it has the prospect of treating a number of central nervous system and other diseases when symptoms first appear, with (yet to be determined) lasting efficacies.

Aspirin was first marketed (before the FDA existed) merely as an analgesic, a pain killer. Worked well for headaches.

Then, was soon found to reduce fevers.

Today, aspirin is commonly "prescribed" to prevent strokes and cardiovascular incidents resulting from blood clotting. Aspirin, among other "benefits" is an anticoagulant.

Recently, clinicians have determined aspirin to help suppress colon cancer.

Aspirin started out as a synthetic analogue of willow bark, which aboriginals chewed for various ailments. Acetylsalicylic acid ("ASA"), the chemical name of aspirin, initially had one therapeutic target, pain. Today, it treats multiple symptoms and diseases.

And, it's cheap and over the counter.

In a decade (or sooner), might this happen with Anavex 2-73? I've already presented the implications of an over the counter form of Anavex 2-73 made available for the safe and effective treatment of insomnia.

(Now, no, don't anyone buy any AVXLs thinking the drug will be on checkout countertops next year, with billions of dollars of corporate revenues. I'm peering across the near horizon, a decade beyond --- just to watch. The science is supportive of my conjecture, but science, alone, does not decide pharmaceutical outcomes.)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News